๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 454 Fuzhou 9 Hangzhou 8 Zhengzhou 7 Yangzhou 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84 Clear sponsor filter
Site location
Shanghai454 Fuzhou9 Hangzhou8 Zhengzhou7 Yangzhou5
All 52 locations
Target enrolment
to
454 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer
NCT05407155Non-small Cell Lung Cancer Metastatic
Fudan University
Not applicable
56
Shanghai
2022-06-09
Active, closed
Effect of FMD on Colorectal Cancer Patients
NCT05384444Fasting Mimicking Diet, Colorectal Cancer
Fudan University
Not applicable
602
Shanghai
2022-06-08
Not yet open
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
NCT05316480Pancreatic Neuroendocrine Neoplasm
Fudan University
Phase 2
42
Shanghai
2022-05-01
Recruiting
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
NCT05247268Endometrial Neoplasm Malignant Stage I
Fudan University
Phase 2
104
Shanghai
2022-03-11
Recruiting
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
NCT05257018Diffuse Large B-cell Lymphoma
Fudan University
Phase 2
83
Shanghai, รœrรผmqi
2022-02-26
Recruiting
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NCT04527419Carcinoma, Non-Small-Cell Lung
Fudan University
Not applicable
545
Shanghai
2022-02-09
Recruiting
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NCT03786003Carcinoma, Non-Small-Cell Lung
Fudan University
Not applicable
1,086
Shanghai
2022-02-09
Recruiting
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
NCT05772208Nasopharyngeal Carcinoma
Fudan University
Phase 3
459
Shanghai
2022-01-01
Recruiting
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
NCT05674305Nasopharyngeal Carcinoma
Fudan University
Phase 3
366
Shanghai
2022-01-01
Recruiting
Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors
NCT05098847Liver Metastasis
Fudan University
Phase 2
25
Shanghai
2021-10-29
Recruiting
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
NCT04520074Ovarian Cancer
Fudan University
Phase 3
590
Shanghai
2021-10-08
Recruiting
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
NCT05057052Liver Metastases, Colorectal Cancer Metastatic
Fudan University
Phase 2
25
Shanghai
2021-09-26
Recruiting
Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma
NCT05057845Advanced Hepatocellular Carcinoma
Fudan University
Phase 2
25
Shanghai
2021-09-26
Active, closed
Health Benefits of Air Purifiers in Primary School Students
NCT05016271Cardiopulmonary Function, Child
Fudan University
Not applicable
110
Shanghai
2021-09-22
Recruiting
Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer
NCT05059379Breast Cancer, Radiotherapy; Complications, Effect of Radiation Therapy
Fudan University
Phase 3
1,650
Shanghai
2021-09-20
Recruiting
Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer
NCT05446545Ovarian Cancer
Fudan University
Observational
139
Shanghai
2021-09-01
Recruiting
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer
NCT05201430Rectal Cancer
Fudan University
Phase 3
300
Shanghai
2021-08-27
Recruiting
Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer
NCT07776301Breast Cancer
Fudan University
Not applicable
225
Shanghai
2021-08-27
Recruiting
Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
NCT05010681Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
25
Shanghai
2021-08-24
Recruiting
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
NCT04997837Gastric Cancer
Fudan University
Phase 3
433
Shanghai
2021-07-21
Recruiting
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
NCT04954781Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
25
Shanghai
2021-07-14
Active, closed
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
NCT04706598Urinary Bladder Neoplasms, Immunotherapy
Fudan University
Phase 1/2
25
Shanghai
2021-06-09
Recruiting
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
NCT04809025Stomach Neoplasms, Endoscopy, Biopsy, Pathology
Fudan University
Observational
510
Shanghai
2021-05-24
Active, closed
Prepectoral and Subpectoral Implant-based Breast Reconstruction
NCT04688697Breast Carcinoma, Breast Reconstruction
Fudan University
Not applicable
300
Shanghai
2021-05-12
Recruiting
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
NCT05086614Stage II Colorectal Cancer, Stage III Colorectal Cancer
Fudan University
Phase 3
2,500
Shanghai
2021-04-01
Active, closed
A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
NCT04734262Metastatic Breast Cancer
Fudan University
Phase 2
98
Shanghai
2021-04-01
Recruiting
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
NCT06749015Metastatic Colorectal Cancer, BRAF V600 Mutation
Fudan University
Observational
100
Shanghai
2021-03-01
Recruiting
Neoadjuvant Radiation in Locally Advanced Breast Cancer
NCT05479409Breast Neoplasms
Fudan University
Phase 2
70
Shanghai
2021-03-01
Recruiting
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
NCT04687631Colorectal Cancer, Liver Metastases
Fudan University
Phase 3
508
Shanghai
2021-01-14
Recruiting
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
NCT05032768Radiation Dermatitis, Skin Microbiome, Breast Cancer, Reconstructive Surgery
Fudan University
Observational
100
Shanghai
2021-01-01
Recruiting
Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer
NCT04947280Bone Metastases, Breast Cancer
Fudan University
Phase 1/2
120
Shanghai
2021-01-01
Recruiting
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
NCT06369181Neuroendocrine Carcinoma, Non-small Cell Lung Cancer, Histology Transformation
Fudan University
Observational
50
Shanghai
2021-01-01
Recruiting
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
NCT04512534Peripheral T-cell Lymphoma
Fudan University
Phase 2
51
Shanghai
2020-11-13
Active, closed
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
NCT04517214Nasopharyngeal Carcinoma
Fudan University
Phase 2
100
Shanghai
2020-11-01
Recruiting
Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms
NCT04766515Cancer
Fudan University
Observational
6,000
Shanghai
2020-09-01
Recruiting
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
NCT04299581Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
25
Shanghai
2020-07-07
Not yet open
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT04443543Rectal Cancer
Fudan University
Phase 2
222
Shanghai
2020-06-22
Active, closed
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227Esophagus Cancer, Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Radiation Therapy
Fudan University
Phase 2
70
Shanghai
2020-05-30
Active, closed
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
NCT04383275Breast Cancer
Fudan University
Phase 2
367
Shanghai
2020-05-20
Recruiting
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
NCT04281641HER2-positive Breast Cancer
Fudan University
Not applicable
94
Shanghai
2020-04-21
Active, closed
Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)
NCT04296175Triple-negative Breast Cancer
Fudan University
Phase 3
808
Shanghai
2020-03-05
Recruiting
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
NCT04519905Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Survival
Fudan University
Not applicable
320
Nanjing, Shanghai
2020-01-06
Active, closed
an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer
NCT07605663Esophageal Squamous Cell Carcinoma
Fudan University
Observational
890
Shanghai
2020-01-01
Recruiting
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
NCT06195228Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University
Phase 4
800
Fuzhou, Zhengzhou, Wuhan, Hohhot, Shanghai, Shanxi, Hangzhou, Beijing
2020-01-01
Active, closed
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer
NCT04193059Breast Cancer
Fudan University
Phase 3
1,560
Shanghai
2019-12-20
Active, closed
Acute Health Effects of Traffic-Related Air Pollution Exposure
NCT04153539Cardiovascular System, Respiratory System
Fudan University
Not applicable
69
Shanghai
2019-10-09
Recruiting
Sentinel Node Biopsy Vs Observation After Axillary PET
NCT04072653Breast Cancer
Fudan University
Not applicable
1,528
Shanghai
2019-09-04
Active, closed
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
NCT07491211NSCLC (Advanced Non-small Cell Lung Cancer), Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Osimertinib, Stereotactic Radiation
Fudan University
Observational
300
Shanghai, Wuhan
2019-07-19
Recruiting
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC๏ผ‰
NCT03941561Gastric Cancer
Fudan University
Phase 3
1,006
Anqing, Hangzhou, Hefei, Nanchang, Shanghai, Wuhu
2019-01-01
Recruiting
Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery
NCT04025164Breast Cancer
Fudan University
Not applicable
4,052
Guiyang, Suzhou, Dalian, Shanghai
2018-07-01
Recruiting
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
NCT02633553Thymoma
Fudan University
Not applicable
238
Shanghai
2018-01-10
Recruiting
Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer
NCT03125980Locally Advanced Colon Cancer
Fudan University
Phase 3
1,370
Shanghai
2017-05
Active, closed
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
NCT02641847Triple Negative Breast Cancer, Breast Cancer
Fudan University
Phase 2/3
503
Shanghai
2016-01
Recruiting
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
NCT04996732Neoplasms, Survival, Surgery, Radiotherapy
Fudan University
Observational
500,000
Shanghai
2008-01-01
Rows per page Showing 401–454 of 454
Previous 3 4 5
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.